Research & Advanced Technologies

More recent research has led to increased understanding of the mechanisms underlying the body’s loss of sensitivity to insulin (commonly called insulin resistance) in type 2 diabetes and the development of new treatments for these individuals. For example, there is evidence to suggest that exercise and weight reduction both decrease insulin resistance. In fact, numerous studies including a landmark study funded by the NIH (the Diabetes Prevention Program), have shown that these two interventions increase sensitivity to insulin and reduce the development of diabetes in people with pre-diabetes. The prevention of diabetes improves the quality and length of life, but while reducing healthcare costs substantially. In addition, researchers have discovered new medications that improve blood sugar control and reduce the incidence of diabetes and its complications.

  • Advances in Type 1 & Type 2 Diabetes
  • Adrenal Hyperplasia
  • Congenital Hypothyroidism
  • Diabetic Retinopathy
  • Endocrine disorders in Hemoglobinopathies
  • Gestational Diabetes- The Hapo Study
  • Overview of Cellular Transplantation in Diabetes Mellitus
  • Updated approach for the management of Thyroid nodules

Related Conference of Research & Advanced Technologies

March 25-26, 2024

5th Annual Conference on Diabetes

London, UK
July 11-12, 2024

7th Annual Meeting on Diabetes and Endocrinology

Paris, France
September 09-10, 2024

4th European Endocrinology and Diabetes Congress

Paris, France
November 22-23, 2024

20th World Congress on Endocrinology & Diabetes

Amsterdam, Netherlands

Research & Advanced Technologies Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in